The association between serum adhesion molecules and outcome in acute spontaneous intracerebral hemorrhage

Critical Care

Volumn 15, Issue 6, 2011, Pages

  Wang, Hung Chen ^a,b   Lin, Wei Che ^a   Lin, Yu Jun ^a,c   Rau, Cheng Shyuan ^a   Lee, Tsung Han ^a   Chang, Wen Neng ^a   Tsai, Nai Wen ^a   Cheng, Ben Chung ^a,c   Kung, Chia Te ^a   Lu, Cheng Hsien ^a,c  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL SUN YAT SEN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; INTERCELLULAR ADHESION MOLECULE 1; L SELECTIN; PADGEM PROTEIN; VASCULAR CELL ADHESION MOLECULE 1; CELL ADHESION MOLECULE;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; BRAIN HEMORRHAGE; BRAIN INFARCTION; CONTROLLED STUDY; CORRELATIONAL STUDY; DIABETES MELLITUS; FEMALE; GLASGOW COMA SCALE; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HYPERLIPIDEMIA; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NEUROSURGERY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RANKIN SCALE; TREATMENT OUTCOME; ACUTE DISEASE; BLOOD; CHI SQUARE DISTRIBUTION; DISABILITY; MIDDLE AGED; PREDICTIVE VALUE; PROSPECTIVE STUDY; RECEIVER OPERATING CHARACTERISTIC;

ACUTE DISEASE; ADULT; AGED; CELL ADHESION MOLECULES; CEREBRAL HEMORRHAGE; CHI-SQUARE DISTRIBUTION; DISABILITY EVALUATION; E-SELECTIN; FEMALE; HUMANS; INTERCELLULAR ADHESION MOLECULE-1; L-SELECTIN; MALE; MIDDLE AGED; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PROSPECTIVE STUDIES; ROC CURVE; VASCULAR CELL ADHESION MOLECULE-1;

EID: 82055164004     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/cc10568     Document Type: Article

References (32)

1. Dennis MS, Burn JP, Sandercock PA, Bamford JM, Wade DT, Warlow CP. Long-term survival after first-ever stroke: the Oxfordshire Community Stroke Project. Stroke 1993, 24:796-800. 10.1161/01.STR.24.6.796, 8506550.
2. Brown RD, Whisnant JP, Sicks JD, O'Fallon WM, Wiebers DO. Stroke incidence, prevalence, and survival: secular trends in Rochester, Minnesota, through 1989. Stroke 1996, 27:373-380.
3. Mayo NE, Neville D, Kirkland S, Ostbye T, Mustard CA, Reeder B, Joffres M, Brauer G, Levy AR. Hospitalization and case-fatality rates for stroke in Canada from 1982 through 1991. The Canadian Collaborative Study Group of Stroke Hospitalizations. Stroke 1996, 27:1215-1220. 10.1161/01.STR.27.7.1215, 8685931.
4. Wang J, Dore S. Inflammation after intracerebral hemorrhage. J Cereb Blood Flow Metab 2007, 27:894-908.
5. Aronowski J, Hall CE. New horizons for primary intracerebral hemorrhage treatment: experience from preclinical studies. Neurol Res 2005, 27:268-279. 10.1179/016164105X25225, 15845210.
6. Gong C, Hoff JT, Keep RF. Acute inflammatory reaction following experimental intracerebral hemorrhage in rat. Brain Research 2000, 871:57-65. 10.1016/S0006-8993(00)02427-6, 10882783.
7. Ma Q, Manaenko A, Khatibi NH, Chen W, Zhang JH, Tang J. Vascular adhesion protein-1 inhibition provides antiinflammatory protection after an intracerebral hemorrhagic stroke in mice. J Cereb Blood Flow Metab 2011, 31:881-893. 10.1038/jcbfm.2010.167, 20877383.
8. Yilmaz G, Granger DN. Cell adhesion molecules and ischemic stroke. Neurol Res 2008, 30:783-793. 10.1179/174313208X341085, 2748428, 18826804.
9. Barone FC, Feuerstein GZ. Inflammatory mediators and stroke: new opportunities for novel therapeutics. J Cereb Blood Flow Metab 1999, 19:819-834.
10. Emsley HC, Tyrrell PJ. Inflammation and infection in clinical stroke. J Cereb Blood Flow Metab 2002, 22:1399-1419.
11. Endres M, Laufs U, Merz H, Kaps M. Focal expression of intercellular adhesion molecule-1 in the human carotid bifurcation. Stroke 1997, 28:77-82. 10.1161/01.STR.28.1.77, 8996493.
12. Bevilacqua MP. Endothelial-leukocyte adhesion molecules. Annu Rev Immunol 1993, 11:767-804. 10.1146/annurev.iy.11.040193.004003, 8476577.
13. Springer TA. Leucocyte adhesion to cells. Scand J Immunol 1990, 32:211-216. 10.1111/j.1365-3083.1990.tb02912.x, 2205903.
14. Hafler DA, Weiner HL. MS: a CNS and systemic autoimmune disease. Immunol Today 1989, 10:104-107. 10.1016/0167-5699(89)90236-3, 2472810.
15. Cannella B, Cross AH, Raine CS. Upregulation and coexpression of adhesion molecules correlate with relapsing autoimmune demyelination in the central nervous system. J Exp Med 1990, 172:1521-1524. 10.1084/jem.172.5.1521, 2188652, 2172438.
16. Kaynar MY, Tanriverdi T, Kafadar AM, Kacira T, Uzun H, Aydin S, Gumustas K, Dirican A, Kuday C. Detection of soluble intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in both cerebrospinal fluid and serum of patients after aneurysmal subarachnoid hemorrhage. J Neurosurg 2004, 101:1030-1036. 10.3171/jns.2004.101.6.1030, 15597765.
17. Kraus J, Oschmann P, Leis S, Neundorfer B, Heckmann JG. High concentrations of sVCAM-1 and sICAM-1 in the cerebrospinal fluid of patients with intracerebral haemorrhage are associated with poor outcome. J Neurol Neurosurg Psychiatry 2002, 73:346-347. 10.1136/jnnp.73.3.346, 1738013, 12185182.
18. Bamford JM, Sandercock PA, Warlow CP, Slattery J. Interobserver agreement for the assessment of handicap in stroke patients [letter]. Stroke 1989, 20:828. 10.1161/01.STR.20.6.828, 2728057.
19. Cerebrovascular diseases: prevention, treatment, and rehabilitation. Report of a WHO meeting. World Health Organ Tech Rep Ser 1971, 469:1-57.
20. Kraus J, Gerriets T, Leis S, Stolz E, Oschmann P, Heckmann JG. Time course of VCAM-1 and ICAM-1 in CSF in patients with basal ganglia haemorrhage. Acta Neurol Scand 2007, 116:49-55. 10.1111/j.1600-0404.2006.00790.x, 17587255.
21. Wang HC, Lin WC, Yang TM, Lin YJ, Chen WF, Tsai NW, Chang WN, Lu CH. Risk factors for acute symptomatic cerebral infarctions after spontaneous supratentorial intra-cerebral hemorrhage. J Neurology 2009, 256:1281-1287.
22. Armstrong FS, Hayes GJ. Segmental cerebral arterial constriction associated with pheochromocytoma: report of a case with arteriogram. J Neurosurg 1961, 18:843-846. 10.3171/jns.1961.18.6.0843, 13862369.
23. Friedman P, Gass H, Magidson M. vasospasm with an unruptured and unoperated aneurysm. Surg Neurol 1983, 19:21-25. 10.1016/0090-3019(83)90204-5, 6828990.
24. Smith RA, Collier HF, Underwood FO. Cerebral vasospasm following myelography. Surg Neurol 1973, 1:87-90.
25. White RP, Hagen AA, Morgan H, Dawson WN, Robertson JT. Experimental study on the genesis of vasospasm. Stroke 1975, 6:52-57. 10.1161/01.STR.6.1.52, 1111183.
26. Kobayashi H, Hayashi M, Kobayashi S, Kabuto M, Handa Y, Kawano H, Ide H. Cerebral vasospasm and vasoconstriction caused by endothelin. Neurosurgery 1991, 28:673-679. 10.1227/00006123-199105000-00006, 1876245.
27. Tsai NW, Lin TK, Chang WN, Jan CR, Huang CR, Chen SD, Cheng KY, Chiang YF, Wang HC, Yang TM, Lin YJ, Lin WC, Chang HW, Lee LH, Lu CH. Statin pre-treatment is associated with lower platelet activity and favorable outcome in patients with acute non-cardio-embolic ischemic stroke. Crit Care 2011, 15:R163. 10.1186/cc10303, 21740551.
28. Leker RR, Khoury ST, Rafaeli G, Shwartz R, Eichel R, Tanne D, . NASIS Investigators Prior use of statins improves outcome in patients with intracerebral hemorrhage: prospective data from the National Acute Stroke Israeli Surveys (NASIS). Stroke 2009, 40:2581-2584. 10.1161/STROKEAHA.108.546259, 19407227, NASIS Investigators.
29. White HD, Simes RJ, Anderson NE, Hankey GJ, Watson JD, Hunt D, Colquhoun DM, Glasziou P, MacMahon S, Kirby AC, West MJ, Tonkin AM. Pravastatin therapy and the risk of stroke. N Engl J Med 2000, 343:317-326. 10.1056/NEJM200008033430502, 10922421.
30. Qureshi AI, Ling GS, Khan J, Suri MF, Miskolczi L, Guterman LR, Hopkins LN. Quantitative analysis of injured, necrotic, and apoptotic cells in a new experimental model of intracerebral hemorrhage. Crit Care Med 2001, 29:152-157. 10.1097/00003246-200101000-00030, 11176176.
31. Kwak BR, Mach F. Statins inhibit leukocyte recruitment: new evidence for their anti-inflammatory properties. Arterioscler Thromb Vasc Biol 2001, 21:1256-1258.
32. Veillard NR, Mach F. Statins: the new aspirin?. Cell Mol Life Sci 2002, 59:1771-1786. 10.1007/PL00012505, 12530513.